SCHEMBL209907

SCHEMBL209907

CC(=O)N(NCc1cccc(F)c1F)[C@H](COC(=O)Nc1cc2ccccc2cn1)CC(O)COP(=O)(O)O

nearest known ligand 0.40

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
PIN1 Q13526 2/20 0.40
NOTUM Q6P988 1/20 0.33
DYRK1A Q13627 3/20 0.32
GSK3B P49841 2/20 0.32
WNT1 P04628 1/20 0.32
CTSK P43235 1/20 0.31
MAOB P27338 1/20 0.31
GCK P35557 2/20 0.30
RARA P10276 1/20 0.30
RARB P10826 1/20 0.30
RARG P13631 1/20 0.30
NTRK1 P04629 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL213746 1.00 PIN1 (0.40) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL209909 1.00 PIN1 (0.40) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL212112 1.00 PIN1 (0.40) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL211784 0.94 PIN1 (0.36) PIN1DYRK1AGSK3BWNT1MAOB
SCHEMBL211743 0.94 PIN1 (0.40) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL211745 0.94 PIN1 (0.40) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL210016 0.93 PIN1 (0.34) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL210361 0.93 PIN1 (0.34) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL210014 0.93 PIN1 (0.34) PIN1NOTUMDYRK1AGSK3BWNT1
SCHEMBL211503 0.93 PIN1 (0.34) PIN1NOTUMDYRK1AGSK3BWNT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8759374-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2014-06-24 US claimed
US-20120135964-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2012-05-31 US claimed
US-8088793-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2012-01-03 US claimed
US-8895582-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2014-11-25 US disclosed
US-8759374-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2014-06-24 US disclosed
US-20130053348-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2013-02-28 US disclosed
US-20120135964-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS QIAN XIANGPING (US) 2012-05-31 US disclosed
US-8088793-B2 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. (US) 2012-01-03 US disclosed
US-20090275537-A1 Certain chemical entities, compositions, and methods CYTOKINETICS, INC. 2009-11-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090275537-A1 Certain chemical entities, compositions, and methods MYLK, MYH2, MYH10 PIN1 4267/4885NOTUM 2164/4885DYRK1A 4356/4885
US-20120135964-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS MYLK, MYH2, MYH10 PIN1 4267/4885NOTUM 2164/4885DYRK1A 4356/4885
US-20130053348-A1 CERTAIN CHEMICAL ENTITIES, COMPOSITIONS, AND METHODS MYLK, MYH2, MYH10 PIN1 4267/4885NOTUM 2164/4885DYRK1A 4356/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.